For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
14
views
0
references
 Top references
cited by
10
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To report the clinical experience with a second-generation of temporary implantable nitinol device (iTIND; Medi-Tate Ltd, Or-Akiva, Israel) for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) after 1 year of follow-up.

          Related collections

          Author and article information

          Journal
          Journal ID (iso-abbrev): BJU Int
          Title: BJU international
          Publisher: Wiley
          ISSN (Electronic): 1464-410X
          ISSN (Print): 1464-4096
          Publication date (Electronic): June 2019
          Volume: 123
          Issue: 6
          Affiliations
          [1 ] Division of Urology, Department of Oncology- School of Medicine, San Luigi Hospital, University of Turin, Orbassano (Turin), Italy.
          [2 ] Division of Urology, Spital Thurgau, Frauenfeld, Switzerland.
          [3 ] Division of Urology, University College London Hospitals, London, UK.
          [4 ] Division of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
          [5 ] Division of Urology, Gent University Hospital, Ghent, Belgium.
          [6 ] Division of Urology, Queen Mary Hospital, Hong Kong City, Hong Kong.
          [7 ] Division of Urology, La Paz University Hospital, Madrid, Spain.
          [8 ] Division of Urology, CHIREC Cancer Institute (CCI), Urology Brussels, Brussels, Belgium.
          [9 ] Division of Urology, Frimley Health, London, UK.
          Article
          DOI: 10.1111/bju.14608
          PubMed ID: 30382600
          SO-VID: 391389ba-3bff-46e1-82f9-8e434683b827
          Copyright © © 2018 The Authors BJU International © 2018 BJU International Published by John Wiley & Sons Ltd.
          History

          Keywords: #LUTS,#UroBPH,BPH,iTIND,minimally invasive techniques,nitinol,urethral implantable device
          Data availability:
          Keywords: #LUTS, #UroBPH, BPH, iTIND, minimally invasive techniques, nitinol, urethral implantable device

          Comments

          Comment on this article